✨ Medicines Act Notices




1334 NEW ZEALAND GAZETTE, No. 48 29 APRIL 2010

Medicines Act 1981

Consent to the Distribution of a New Related Product

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new related product set out in the Schedule hereto:

Schedule

Product: Sunsilk Purifying Scalp Care
Active Ingredient: Pyrithione zinc 0.98%w/w
Dosage Form: Shampoo
New Zealand Sponsor: Unilever Australasia Division of Unilever New Zealand Limited
Manufacturer: Unilever Australasia, North Rocks, Australia

Dated this 22nd day of April 2010.

ANTHONY HILL, Deputy Director-General, Regulation and Governance Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go3141

Renewal of Provisional Consent to the Distribution of Medicines

Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicines set out in the Schedule hereto:

Schedule

Product: Gutron
Active Ingredient: Midodrine hydrochloride 2.5mg
Dosage Form: Tablet
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturers: Nycomed Austria GmbH, Linz, Austria
Nycomed Danmark ApS, Hvidovre, Denmark

Note: This renewed consent is valid for two years from 30 April 2010.

Product: Gutron
Active Ingredient: Midodrine hydrochloride 5mg
Dosage Form: Tablet
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturers: Nycomed Austria GmbH, Linz, Austria
Nycomed Danmark ApS, Hvidovre, Denmark

Note: This renewed consent is valid for two years from 30 April 2010.

Dated this 22nd day of April 2010.

ANTHONY HILL, Deputy Director-General, Regulation and Governance Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go3142

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Anatrole
Active Ingredient: Anastrozole 1mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Synthon Hispania SL, Barcelona, Spain

Product: Astromide
Active Ingredient: Temozolomide 5mg
Dosage Form: Capsule
New Zealand Sponsor: Schering-Plough a division of Schering-Plough Animal Health Limited
Manufacturer: Orion Pharma, Turku, Finland

Product: Astromide
Active Ingredient: Temozolomide 20mg
Dosage Form: Capsule
New Zealand Sponsor: Schering-Plough a division of Schering-Plough Animal Health Limited
Manufacturer: Orion Pharma, Turku, Finland



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2010, No 48





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of a New Related Product

πŸ₯ Health & Social Welfare
22 April 2010
Medicines Act 1981, Sunsilk Purifying Scalp Care, Pyrithione zinc, Shampoo, Unilever Australasia
  • ANTHONY HILL, Deputy Director-General, Regulation and Governance Directorate, Ministry of Health

πŸ₯ Renewal of Provisional Consent to the Distribution of Medicines

πŸ₯ Health & Social Welfare
22 April 2010
Medicines Act 1981, Gutron, Midodrine hydrochloride, Tablet, Douglas Pharmaceuticals Limited, Nycomed Austria GmbH, Nycomed Danmark ApS
  • ANTHONY HILL, Deputy Director-General, Regulation and Governance Directorate, Ministry of Health

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
22 April 2010
Medicines Act 1981, Anatrole, Anastrozole, Film coated tablet, Mylan New Zealand Limited, Synthon Hispania SL, Astromide, Temozolomide, Capsule, Schering-Plough, Orion Pharma
  • ANTHONY HILL, Deputy Director-General, Regulation and Governance Directorate, Ministry of Health